[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604004":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":21,"responsibleParty":40,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":7,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":64,"overallStatus":69,"whyStopped":7,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Assiut University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Mohammad S Mohammad, MBBS","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+201095027359","mohamed.17289893@med.aun.edu.eg",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Amira H Abdel Aziz, MD","+201092094687","amirahassan13@aun.edu.eg",[22],{"facility":23,"status":7,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Assiut university Hospitals","Asyut","Asyut Governorate","71511","Egypt","EG",{"type":30,"coordinates":31},"Point",[32,33],31.18368,27.18096,{"lat":33,"lon":32},[36],{"name":37,"role":14,"phone":38,"phoneExt":7,"email":39},"Gamal A Badr, MD","+208822080150","vp_grad@aun.edu.eg",{"type":11,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Mohammad Sayed Mohammad Bakheet","Resident of internal medicine department","100604004","prognostic-impacts-of-lipid-profile-and-bmi-in-adult-aml-100604004",false,"NCT07143877","Prognostic Impacts of Lipid Profile and BMI in Adult AML","Prognostic Impacts of Lipid Profile and Body Mass Index in Adult Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy","AML\u002FBMI","Inclusion Criteria:\n\n* Adult patients (≥18yearsold) newly diagnosed with AML.\n* Patients eligible for intensive induction chemotherapy.\n* Patients who have given informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Patients with secondary or relapsed AML.\n* Patients currently using lipid-lowering medications (e.g., statins).\n* Patients with known endocrine or metabolic disorders affecting BMI or lipid profile (e.g., uncontrolled diabetes, hypothyroidism, Cushing's syndrome).\n* Pregnant or lactating women.\n* Patients unwilling or unable to complete the study protocol.\n* Patients with M3 subtype of AML.","ALL","18 Years",{"count":54,"type":55},200,"ESTIMATED","35 Days","OBSERVATIONAL","The goal of this observational study is to evaluate the changes in lipid profile parameters (total cholesterol, triglycerides, HDL-C, and LDL-C) in adult AML patients before and after intensive induction chemotherapy. The main questions it aims to answer are:\n\n* Are there correlations between metabolic changes (in lipid profile and BMI) and treatment outcomes, including remission status and incidence of chemotherapy-related complications?\n* Can the baseline lipid profile and BMI serve as prognostic markers for response to induction chemotherapy.?\n\nParticipants will be observed before and after induction chemotherapy regarding their lipid profile, and BMI, observing any correlations between the different results with any complications, and with remission status.",[60,61,62,63],"AML (Acute Myeloid Leukemia)","BMI","Lipid Profile","Induction Chemotherapy",[65,61,66,67,68],"AML","Lipid profile","Adult","Induction chemotherapy","NOT_YET_RECRUITING","2025-08-23",{"date":72,"type":73},"2025-08-27","ACTUAL",{"date":75,"type":55},"2025-11-15",{"date":77,"type":55},"2027-03-15",{"name":5,"class":6},1]